Mavacoxib , identified by CAS Number 170569-88-7 , is a highly non-steroidal anti-inflammatory drug (NSAID) widely used in veterinary medicine-primarily for the treatment of osteoarthritis and chronic pain in dogs . As a selective COX-2 inhibitor , Mavacoxib reduces inflammation and pain while minimizing effective adverse gastrointestinal and renal effects commonly associated with non-selective NSAIDs.

Its long duration of action and strong safety profile make it a preferred active pharmaceutical ingredient (API) in modern veterinary formulations.

Product Details & Chemical Information

These physicochemical properties ensure excellent stability and consistent performance when formulated into veterinary medicines.

What is Mavacoxib?

Mavacoxib is a potent active pharmaceutical ingredient (API) belonging to the NSAID class. Its therapeutic effects come from selectively inhibiting cyclooxygenase-2 (COX-2) -the enzyme mainly responsible for producing inflammatory prostaglandins.

By targeting COX-2 more specifically than COX-1, Mavacoxib delivers strong anti-inflammatory and analgesic effects with a lower risk of gastrointestinal and renal complications .

Thanks to its long half-life, Mavacoxib offers prolonged pain relief, making it particularly suitable for chronic conditions.

Veterinary Applications

✔Osteoarthritis Management in Dogs

Osteoarthritis is a common degenerative joint disease in aging dogs, leading to:

• Joint pain
• Stiffness
• Reduced mobility
• Decreased quality of life

Mavacoxib effectively controls inflammation in affected joints, providing sustained relief and improving mobility.

✔Treatment of Pain and Inflammation from Other Conditions

Beyond osteoarthritis, Mavacoxib is also beneficial for managing:

• Postoperative pain
• Soft tissue injuries
• Musculoskeletal inflammation
• Chronic degenerative conditions

Its long-acting nature reduces the dosing frequency, improving compliance for pet owners.

✔ Advantages Over Traditional NSAIDs

Because Mavacoxib is highly selective for COX-2, it:

• Reduces gastrointestinal irritation
• Lowers renal toxicity risk
• Provides a safer long-term therapy option
• Offers prolonged pain control with fewer doses

These features make it a popular choice among veterinarians for chronic pain management.

Benefits of Mavacoxib API

• High therapeutic potency for inflammation reduction
• Fewer side effects due to COX-2 selectivity
• Ideal for chronic use because of extended duration of action
• Improves overall activity and comfort in dogs with osteoarthritis
• High purity and quality when produced under strict in-house standards

Packaging & Delivery

We offer flexible packaging options to meet global customer needs:

• Customizable packaging (glass bottles, foil bags, small or bulk quantities)
• Fast delivery via express couriers (eg, FedEx)
• Air transportation for international shipments

FAQs

Q: Can the package of your products be customized?

A: Yes. Various packaging sizes and materials can be provided, from small sample packs to full bulk packaging.

Q: How do you deliver your products?

A: Products can be shipped by express services like FedEx or via air freight depending on customer requirements.

Conclusion

Mavacoxib (CAS 170569-88-7) is an essential veterinary API that provides safe, effective, and long-lasting pain and inflammation relief for dogs-especially those suffering from osteoarthritis. With its strong COX-2 selectivity, reduced side-effect profile, and superior pharmacological performance, Mavacoxib represents a trusted solution for improving canine comfort and mobility.

Its stability, high purity, and excellent therapeutic value make it a preferred choice for veterinary pharmaceutical manufacturers worldwide.